Search results for "Opioid use disorder"
Routine opioid use disorder screening fails to significantly increase new diagnosis rates
This may be due to the sensitivity of the screening instrument, compounded by the stigma of opioid use disorder; addressing the latter may increase the instrument's sensitivity, the authors suggest.
https://immattersacp.org/weekly/archives/2023/10/17/2.htm
17 Oct 2023
New 'weighs' to treat obesity
Even as the data on weight loss drugs mount, physicians need to help patients navigate potentially prohibitive costs and a continuing need for lifestyle change.
https://immattersacp.org/archives/2024/03/new-weighs-to-treat-obesity.htm
1 Mar 2024
Telehealth visits may improve outcomes for opioid use disorder
A cross-sectional study of U.S. insurance claims found that buprenorphine initiation during a telehealth visit was associated with a 36% lower overdose rate than in person and that patients in the former group were more likely to refill their prescriptions.
https://immattersacp.org/weekly/archives/2023/09/12/1.htm
12 Sep 2023
Learn the latest on excessive alcohol use, opioid use disorder
This month's issue addresses alcohol use and misuse, prescribing buprenorphine, and improving health care's response to future pandemics.
https://immattersacp.org/archives/2023/03/learn-the-latest-on-excessive-alcohol-use-opioid-use-disorder.htm
1 Mar 2023
MKSAP Quiz: 3-year history of pain in muscles, joints
A 47-year-old woman is evaluated for a 3-year history of pain in all of her muscles and joints. She is a commercial truck driver. Her sleep is poor, and she awakens unrefreshed. She completes a fibromyalgia diagnostic questionnaire and meets the criteria for fibromyalgia. She has anxiety and depression. Following a physical exam and lab results, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2024/04/02/3.htm
2 Apr 2024
One-third of primary care physicians do not support medications for opioid use disorder
Fewer than a quarter of surveyed primary care physicians expressed interest in treating patients with opioid use disorder, and only 11.8% were interested in obtaining a waiver to prescribe buprenorphine.
https://immattersacp.org/weekly/archives/2020/04/21/2.htm
21 Apr 2020
Buprenorphine, cannabis, and other periop challenges
An expert at a recent hospital medicine conference reviewed the latest on perioperative management of medications.
https://immattersacp.org/archives/2024/01/buprenorphine-cannabis-and-other-periop-challenges.htm
1 Jan 2024
Drug screens early during treatment for OUD predict risk of return to opioid use
Patients whose urine drug screens in the three weeks after beginning treatment for opioid use disorder (OUD) were negative for opioids had a 13% risk of returning to opioid use compared with 85% for those with three weeks of opioid-positive or missing results.
https://immattersacp.org/weekly/archives/2023/10/10/2.htm
10 Oct 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/11/latest-updates-on-acps-priorities-initiatives.htm
1 Nov 2023
Daily medication appears more cost-effective than monthly injections for opioid use disorder
Over 24 weeks, extended-release naltrexone cost an average of $5,317 more than buprenorphine-naloxone, primarily because the former was more expensive and required a longer detoxification period.
https://immattersacp.org/weekly/archives/2018/12/18/1.htm
18 Dec 2018